Our News

At Sientra, we always have something noteworthy going on.

Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations

Sientra to Launch State-of-the-Art Innovation Facility

Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting

Sientra Receives FDA Approval of PMA Supplement

Sientra Reports the Long-term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest Core Breast Implant Trial To-Date

Sientra Provides Update on FDA Review of U.S. Manufacturing Facility

Sientra Supports Reconstructive Breast Patients with Launch of Full Circle™ Grant Program and Revolutionary Portfolio of Tissue Expanders

Comprehensive Analysis of Long-Term Safety Studies Reaffirms Smooth and Textured Breast Implants as Safe & Important Option for Patients Undergoing Aesthetic or Reconstructive Breast Surgery

Sientra Pledges Support as Platinum Sponsor of Plastic Surgery The Meeting

Sientra Completes Acquisition of Miramar Labs®

Sientra to Acquire Miramar Labs®

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products, Inc.

Sientra Provides Update on Manufacturing Solution

Sientra Acquires bioCorneum Advanced Silicone Gel Scar Management Therapy

Sientra Announces Return of All Products to U.S. Market

Sientra Announces Executive Management Promotions

Sientra Files Registration Statement for Proposed Initial Public Offering

Sientra and RealSelf Announce Exclusive Initiative to Deliver New Education to Women Seeking Breast Augmentation

Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer

Sientra Launches Industry's First-Ever Patient-Centric Capsular Contracture Care Program

Sientra Defeats J&J/Mentor Worldwide Lawsuit: A Victory For Free Competition, Employee Rights And Women's Health

Sientra Raises $65 Million in a Series C Financing to Support Commercialization of its FDA-Approved Silicone Breast Implants

Sientra receives FDA approval of its Silimed-brand portfolio of round and shaped silicone breast implants